effective
in that a number of amino acids, such as lglutamate, L-lysine, L-phenylalanine, L-threonine, larginine, L-isoleucine, L-leusine, L-valine, are practically produced by fermentative methods. The development of gene manipulation technology has provided new methodology in this field. The application of this technology has been used in the following two ways:
(a) a gene coding for an enzyme involved in amino acid biosynthesis can be cloned, followed by inducing mutations to set it free from control mechanisms,1) and (b) the cloned gene can be amplified by a high copy number vector causing elevated level of the enzyme activity in favor of amino acid overproduction.
) and L-proline7) have been genetically derived using recombinant DNAtechnology. Wehave been investigating the molecular breeding of lPhe-and L-Tyr-producing Brevibacterium lactofermentum.
Shikimate kinase is one of the enzymes involved in a common pathway for the aromatic amino acid biosynthesis and an important one in the overproduction of lTyr since it is repressed by L-Tyr.10) The shikimate kinase gene (aroL) of B. lactofermentum has been cloned by Matsui et al.U) In this paper, the gene dosage effect of aroL was studied in relation to improvements in the microbial production of L-Tyr. We cloned the aroL gene by shotgun cloning using an aroL deficient mutant, CS-54 (Phe~, Tyr~, Tip"), which was obtained from a B^lactofermentum wild type strain, AJ12036. The deficiency of the shikimate kinase activity was confirmed in Table I . A shotgun cloning experiment was done using B. lactofermentum AJ1 195714) as a DNA donor strain and pAJ184415) as a vector plasmid with the 823 protoplast transformation method.15' Two recombinant plasmids, pSC5 and pSC24, which complemented the auxotrophy of CS-54, were obtained. The restriction enzyme cleavage map of the two clones showed the identities of the inserts in the opposite direction (Fig. 1) . The introduction of pSC5 into CS-54 restored the enzyme activity ( Table I ). The aroL gene thus obtained seemed to be identical to that described by Matsui et al.,U) according to the cleavage map. L-Tyr producers, MF358 and FT-1, were transformed with the recombinant plasmid containing the aroL gene, and the gene dosage effect on the amino acid productivity was investigated. MF358, a mutant of B. lactofermentum which is resistant to mFP, accumulates both L-Tyr and lPhe, and FT-1, an L-Phe auxotroph derived from MF358, produces L-Tyr alone as described in our previous Ten mg/1 ofCm was added to the medium for plasmid-harboring strains. L-Phe and L-Tyr were analyzed by HPLC.12) Cell extracts for the enzyme assay were prepared from the same culture as the production medium. NT, not tested. paper.12)
The results are showed in Table II spectively, indicating that the repression may be released in FT-1 to some extent. Therefore, the gene dosage effect in FT-1 was more distinguishable than that in MF358, in which the repression was still in effect and the increase in the enzymeactivity was restricted.
The gene engineered L-Tyr producer thus obtained accumulated as much as 21.6g/1 of L-Tyr. The combination of recombinant DNAtechnology with conventional genetic breeding techniques brought about an effective microbial producer of L-Tyr.
